Teva Pharma's most recent trend suggests a bearish bias. One trading opportunity on Teva Pharma is a Bear Call Spread using a strike $45.00 short call and a strike $50.00 long call offers a potential 7.07% return on risk over the next 9 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $45.00 by expiration. The full premium credit of $0.33 would be kept by the premium seller. The risk of $4.67 would be incurred if the stock rose above the $50.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Teva Pharma is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Teva Pharma is bearish.
The RSI indicator is below 20 which suggests that the stock is in oversold territory.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Teva Pharma
Why Momenta Pharmaceuticals, Inc. Jumped Higher Today
Tue, 11 Oct 2016 20:29:38 GMT
Momenta Pharmaceuticals (MNTA) Stock Surges, Barclays Upgrades
Tue, 11 Oct 2016 18:45:00 GMT
Punishment For This Healthcare ETF Could Create Opportunity
Tue, 11 Oct 2016 18:13:24 GMT
Teva Acquires Rights to Oncology Biosimilar Candidates
Tue, 11 Oct 2016 13:25:01 GMT
Mylan Jumps As DOJ Settlement Removes ‘Lingering Concerns'
Mon, 10 Oct 2016 20:03:36 GMT
Also on Market Tamer…
Follow Us on Facebook